Acadia Pharmaceuticals (ACAD) Current Assets (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted Current Assets of $1.2 billion for Q2 2026, up 11.73% on a QoQ basis from $1.1 billion in Q1 2026, and up 27.48% year-over-year from $960.6 million in Q2 2025.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Current Assets (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals has reported Current Assets for 17 years, with the latest figure at $1.2 billion in Q2 2026.
- On a quarterly basis, Current Assets rose 27.48% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 27.48% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 13.19% from the prior year.
- Current Assets was $1.2 billion for Q2 2026 at Acadia Pharmaceuticals, up from $1.1 billion in the prior quarter.
- The five-year high for Current Assets was $1.2 billion in Q2 2026, with the low at $492.6 million in Q2 2023.
- Average Current Assets over 5 years is $757.6 million, with a median of $702.1 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Current Assets slipped 19.55% in 2022, then surged 57.92% in 2024.
- Over 5 years, Current Assets stood at $507.9 million in 2022, then gained by 21.3% to $616.1 million in 2023, then surged by 52.29% to $938.3 million in 2024, then climbed by 13.19% to $1.1 billion in 2025, then increased by 15.29% to $1.2 billion in 2026.
- The last three Current Assets figures came in at $1.2 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Acadia Pharmaceuticals | 4.38 Bn | 3.42 Bn | 279.64 Mn | 1.22 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22 Bn |
| Mar 31, 2026 | 1.10 Bn |
| Dec 31, 2025 | 1.06 Bn |
| Sep 30, 2025 | 1.08 Bn |
| Jun 30, 2025 | 960.55 Mn |
| Mar 31, 2025 | 870.94 Mn |
| Dec 31, 2024 | 938.32 Mn |
| Sep 30, 2024 | 788.28 Mn |
| Jun 30, 2024 | 728.92 Mn |
| Mar 31, 2024 | 675.30 Mn |
| Dec 31, 2023 | 616.13 Mn |
| Sep 30, 2023 | 499.17 Mn |
| Jun 30, 2023 | 492.63 Mn |
| Mar 31, 2023 | 502.85 Mn |
| Dec 31, 2022 | 507.94 Mn |
| Sep 30, 2022 | 521.55 Mn |
| Jun 30, 2022 | 532.52 Mn |
| Mar 31, 2022 | 542.22 Mn |
| Dec 31, 2021 | 617.82 Mn |
| Sep 30, 2021 | 640.92 Mn |
API Access
Acadia Pharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();